Back
Werewolf Therapeutics
IPOHOWL.NASDAQPast

Werewolf Therapeutics

Oncology biotherapeutics company

Company website ↗
Foundation year: 2017
Profitability
+25.31%
IPO date
29/04/2021

About

Total Funding 

$128.2M


Werewolf Therapeutics is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.


Number of employees

11-50


Headquarters

Cambridge, Massachusetts, United States